BACKGROUND Most errors in a clinical chemistry laboratory are due to preanalytical errors.
Preanalytical variability of biospecimens can have significant effects on downstream …

Background Urinary biomarkers for the diagnosis of bladder cancer represents an area of
considerable research which has been tested in both patients presenting with haematuria …

Bacterial infections may cause severe diseases such as tuberculosis, sepsis, nephritis and
cystitis. The rapid and sensitive detection of bacteria is a prerequisite for the treatment of …

Urine cell-free DNA (cfDNA) is a valuable noninvasive biomarker for cancer mutation
detection, infectious disease diagnosis (eg, tuberculosis), organ transplantation monitoring …

This review summarizes usage of genome-editing technologies for metagenomic studies;
these studies are used to retrieve and modify valuable microorganisms for production …

The extraction of genomic DNA is the crucial first step in large-scale epidemiological studies.
Though there are many popular DNA isolation methods from human whole blood, only a few …

Context By 2020 the estimated incidence of genitourinary (GU) cancers (prostate, bladder,
and kidney) will be over 2 million worldwide and responsible for∼ 800 000 deaths. Current …

Background Urogenital schistosomiasis due to Schistosoma haematobium is a serious
underestimated public health problem affecting 112 million people-particularly in sub …

Medical tests are playing an increasingly important role in the diagnosis and treatment of
diseases. Urine tests, blood tests and stool tests together constitute the three major routine …

Background Different methods available for extraction of human genomic DNA suffer from
one or more drawbacks including low yield, compromised quality, cost, time consumption …